SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-19-005547
Filing Date
2019-11-18
Accepted
2019-11-18 08:41:49
Documents
2
Period of Report
2019-11-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1716
2 POA FOR GEORGE ELSTON poa_georgeelston.txt EX-24 3351
  Complete submission text file 0001562180-19-005547.txt   6615
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 124 CHATHAM STREET CHATHAM NJ 07928
Business Address
Elston George (Reporting) CIK: 0001429932 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 191226274